Quantitative parameters of contrast-enhanced ultrasound effectively promote the prediction of cervical lymph node metastasis in papillary thyroid carcinoma
Papillary thyroid carcinoma (PTC), the most common endocrine tumor, often spreads to cervical lymph nodes metastasis (CLNM). Preoperative diagnosis of CLNM is important when selecting surgical strategies. Therefore, we aimed to explore the effectiveness of quantitative parameters of contrast-enhance...
Saved in:
Published in | Drug Discoveries & Therapeutics Vol. 18; no. 1; pp. 44 - 53 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Japan
International Research and Cooperation Association for Bio & Socio-Sciences Advancement
29.02.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Papillary thyroid carcinoma (PTC), the most common endocrine tumor, often spreads to cervical lymph nodes metastasis (CLNM). Preoperative diagnosis of CLNM is important when selecting surgical strategies. Therefore, we aimed to explore the effectiveness of quantitative parameters of contrast-enhanced ultrasound (CEUS) in predicting CLNM in PTC. We retrospectively analyzed 193 patients with PTC undergoing conventional ultrasound (CUS) and CEUS. The CUS features and quantitative parameters of CEUS were evaluated according to PTC size ≤ 10 or > 10 mm, using pathology as the gold standard. For the PTC ≤ 10 mm, microcalcification and multifocality were significantly different between the CLNM (+) and CLNM (-) groups (both P < 0.05). For the PTC > 10 mm, statistical significance was noted between the two groups with respect to the margin, capsule contact, and multifocality (all P < 0.05). For PTC ≤ 10 mm, there was no significant difference between the CLNM (+) and CLNM (-) groups in all quantitative parameters of CEUS (all P > 0.05). However, for PTC > 10 mm, the peak intensity (PI), mean transit time, and slope were significantly associated with CLNM (all P < 0.05). Multivariate analysis showed that PI > 5.8 dB was an independent risk factor for predicting CLNM in patients with PTC > 10 mm (P < 0.05). The area under the curve of PI combined with CUS (0.831) was significantly higher than that of CUS (0.707) or PI (0.703) alone in the receiver operator characteristic curve analysis (P < 0.05). In conclusion, PI has significance in predicting CLNM for PTC > 10 mm; however, it is not helpful for PTC ≤ 10 mm. |
---|---|
AbstractList | Papillary thyroid carcinoma (PTC), the most common endocrine tumor, often spreads to cervical lymph nodes metastasis (CLNM). Preoperative diagnosis of CLNM is important when selecting surgical strategies. Therefore, we aimed to explore the effectiveness of quantitative parameters of contrast-enhanced ultrasound (CEUS) in predicting CLNM in PTC. We retrospectively analyzed 193 patients with PTC undergoing conventional ultrasound (CUS) and CEUS. The CUS features and quantitative parameters of CEUS were evaluated according to PTC size ≤ 10 or > 10 mm, using pathology as the gold standard. For the PTC ≤ 10 mm, microcalcification and multifocality were significantly different between the CLNM (+) and CLNM (-) groups (both P < 0.05). For the PTC > 10 mm, statistical significance was noted between the two groups with respect to the margin, capsule contact, and multifocality (all P < 0.05). For PTC ≤ 10 mm, there was no significant difference between the CLNM (+) and CLNM (-) groups in all quantitative parameters of CEUS (all P > 0.05). However, for PTC > 10 mm, the peak intensity (PI), mean transit time, and slope were significantly associated with CLNM (all P < 0.05). Multivariate analysis showed that PI > 5.8 dB was an independent risk factor for predicting CLNM in patients with PTC > 10 mm (P < 0.05). The area under the curve of PI combined with CUS (0.831) was significantly higher than that of CUS (0.707) or PI (0.703) alone in the receiver operator characteristic curve analysis (P < 0.05). In conclusion, PI has significance in predicting CLNM for PTC > 10 mm; however, it is not helpful for PTC ≤ 10 mm. |
ArticleNumber | 2023.01095 |
Author | Li, Lisha Zhan, Jia Chen, Lin Liu, Yingchun Su, Biao Liu, Hui Chai, Qiliang Fang, Liang Wang, Ling |
Author_xml | – sequence: 1 fullname: Su, Biao organization: Department of Ultrasound, Huadong Hospital, Fudan University, Shanghai, China – sequence: 2 fullname: Li, Lisha organization: Department of Reproductive Immunology, Obstetrics and Gynecology Hospital, Fudan University, Shanghai, China – sequence: 3 fullname: Liu, Yingchun organization: Department of Ultrasound, Huadong Hospital, Fudan University, Shanghai, China – sequence: 4 fullname: Liu, Hui organization: Department of Ultrasound, Huadong Hospital, Fudan University, Shanghai, China – sequence: 5 fullname: Zhan, Jia organization: Department of Ultrasound, Huadong Hospital, Fudan University, Shanghai, China – sequence: 6 fullname: Chai, Qiliang organization: Department of Ultrasound, Huadong Hospital, Fudan University, Shanghai, China – sequence: 7 fullname: Fang, Liang organization: Department of Ultrasound, Huadong Hospital, Fudan University, Shanghai, China – sequence: 8 fullname: Wang, Ling organization: Department of Reproductive Immunology, Obstetrics and Gynecology Hospital, Fudan University, Shanghai, China – sequence: 9 fullname: Chen, Lin organization: Department of Ultrasound, Huadong Hospital, Fudan University, Shanghai, China |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38355122$$D View this record in MEDLINE/PubMed |
BookMark | eNpFUU1P3DAQtSqqQilXjsh_IFtPPp0jgkIrIVWVOPQWTexx1yixI9uLtL-lf7bOLmx9GI9m3nsz9vvMzpx3xNg1iE3TyPKr1mlTirLaCBB984FdgJRQdLL-fXbKKzhnVzG-iHyaWoJsPrHzSlZNA2V5wf7-2qFLNmGyr8QXDDhTohC5N1x5lwLGVJDbolOk-W5aC37nNCdjSK2kac-X4GefiKdtlgikbW54d5Cg8GoVTnzaz8uWO6-J5wFZFKON3Lo8crHThGGf2fvgreYKg7LOz_iFfTQ4Rbp6uy_Z88O357vvxdPPxx93t0-FqkuZCoOAZLQe-w6gq_qmrQWMnQDd912rxlwUgLo1QiiNfY0GTAvQU9WOqh-rS3ZzlF1240x6WIKd8z7D-ydlwOYIUMHHGMicICCG1YghGzGsRgwHIzLh_kh4ye_8Qyc4hmTVRAc4yAHW8J92aqsthoFc9Q91FJhw |
Cites_doi | 10.1089/thy.2008.0243 10.5858/2006-130-1057-PTCAO 10.1002/dc.20898 10.1055/s-0044-101254 10.3892/etm.2017.5087 10.1097/MD.0000000000014051 10.1097/MD.0000000000013325 10.1016/j.ejrad.2019.108801 10.1177/1758835920942367 10.1155/2013/965212 10.5662/wjm.v12.i5.448 10.2147/CMAR.S169741 10.1007/s00261-023-03804-5 10.2147/CMAR.S265756 10.3389/fendo.2023.1052862 10.3892/mco.2016.1053 10.1371/journal.pone.0090674 10.1089/thy.2015.0020 10.3322/caac.21439 10.1016/j.ultrasmedbio.2016.11.009 10.1016/j.ejso.2017.07.008 10.2147/CMAR.S199921 10.3389/fendo.2021.666315 10.1186/s12885-019-5835-6 10.1097/MD.0000000000002558 10.1097/MD.0000000000008365 10.1038/s41598-018-36171-z 10.1109/TUFFC.2010.1550 10.1002/hed.25941 10.1016/S0039-6060(03)00424-0 10.1016/j.bjorl.2020.05.004 10.1002/jum.15315 10.1016/j.surg.2008.09.003 10.3389/fendo.2022.812475 10.1007/s11547-019-01129-2 10.1002/jcu.23073 10.21037/gs-20-75 10.1016/j.ejso.2016.07.002 10.1089/thy.2009.1608 10.1016/j.canep.2015.04.015 10.7863/jum.2013.32.3.429 10.3233/CH-221545 10.2217/fon-2020-0069 10.1210/jc.2014-3825 10.21037/gs.2020.03.02 10.1530/EC-22-0341 10.1007/s40618-018-0908-y 10.3233/CH-180454 10.1507/endocrj.EJ12-0311 10.7863/jum.2012.31.6.915 10.1177/0300060517708943 |
ContentType | Journal Article |
Copyright | 2024 International Research and Cooperation Association for Bio & Socio-Sciences Advancement |
Copyright_xml | – notice: 2024 International Research and Cooperation Association for Bio & Socio-Sciences Advancement |
DBID | AAYXX CITATION NPM |
DOI | 10.5582/ddt.2023.01095 |
DatabaseName | CrossRef PubMed |
DatabaseTitle | CrossRef PubMed |
DatabaseTitleList | PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1881-784X |
EndPage | 53 |
ExternalDocumentID | 38355122 10_5582_ddt_2023_01095 article_ddt_18_1_18_2023_01095_article_char_en |
Genre | Journal Article |
GroupedDBID | --- 53G ABDBF ADBBV ALMA_UNASSIGNED_HOLDINGS BAWUL DIK EBD EMOBN ESX F5P JSF JSH KQ8 MK0 OK1 P2P RJT RZJ SV3 TUS 7.U AAYXX ACUHS CITATION NPM |
ID | FETCH-LOGICAL-c428t-fa1aefddb971173956401b701d9976cb11701ad6f00cda94af1f6119e36bc9b3 |
ISSN | 1881-7831 |
IngestDate | Mon Jul 21 05:57:13 EDT 2025 Tue Jul 01 01:15:40 EDT 2025 Fri Apr 12 19:05:15 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | quantitative parameter cervical lymph node metastasis papillary thyroid carcinoma contrast-enhanced ultrasound |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c428t-fa1aefddb971173956401b701d9976cb11701ad6f00cda94af1f6119e36bc9b3 |
OpenAccessLink | https://www.jstage.jst.go.jp/article/ddt/18/1/18_2023.01095/_article/-char/en |
PMID | 38355122 |
PageCount | 10 |
ParticipantIDs | pubmed_primary_38355122 crossref_primary_10_5582_ddt_2023_01095 jstage_primary_article_ddt_18_1_18_2023_01095_article_char_en |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2024/02/29 |
PublicationDateYYYYMMDD | 2024-02-29 |
PublicationDate_xml | – month: 02 year: 2024 text: 2024/02/29 day: 29 |
PublicationDecade | 2020 |
PublicationPlace | Japan |
PublicationPlace_xml | – name: Japan |
PublicationTitle | Drug Discoveries & Therapeutics |
PublicationTitleAlternate | DD&T |
PublicationYear | 2024 |
Publisher | International Research and Cooperation Association for Bio & Socio-Sciences Advancement |
Publisher_xml | – name: International Research and Cooperation Association for Bio & Socio-Sciences Advancement |
References | 39. Li QL, Ma T, Wang ZJ, Huang L, Liu W, Chen M, Sang T, Ren XG, Tong J, Cao CL, Dong J, Li J. The value of contrast-enhanced ultrasound for the diagnosis of metastatic cervical lymph nodes of papillary thyroid carcinoma: A systematic review and meta-analysis. J Clin Ultrasound. 2022; 50:60-69. 25. Perrier ND, Brierley JD, Tuttle RM. Differentiated and anaplastic thyroid carcinoma: Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin. 2018; 68:55-63. 5. Baek SK, Jung KY, Kang SM, Kwon SY, Woo JS, Cho SH, Chung EJ. Clinical risk factors associated with cervical lymph node recurrence in papillary thyroid carcinoma. Thyroid. 2010; 20:147-152. 41. Zhan J, Diao X, Chen Y, Wang W, Ding H. Predicting cervical lymph node metastasis in patients with papillary thyroid cancer (PTC) - Why contrast-enhanced ultrasound (CEUS) was performed before thyroidectomy. Clin Hemorheol Microcirc. 2019; 72:61-73. 6. Xu S, Yao J, Zhou W, Chen L, Zhan W. Clinical characteristics and ultrasonographic features for predicting central lymph node metastasis in clinically node‐negative papillary thyroid carcinoma without capsule invasion. Head Neck. 2019; 41:3984-3991. 15. Li J, Liu J, Qian L. Suspicious ultrasound characteristics correlate with multiple factors that predict central lymph node metastasis of papillary thyroid carcinoma: Significant role of HBME-1. Eur J Radiol. 2020; 123:108801. 7. Zhang L, Yang J, Sun Q, Liu Y, Liang F, Liu Z, Chen G, Chen S, Shang Z, Li Y, Li X. Risk factors for lymph node metastasis in papillary thyroid microcarcinoma: older patients with fewer lymph node metastases. Eur J Surg Oncol. 2016; 42:1478-1482. 35. Sidhu P, Cantisani V, Dietrich C, et al. The EFSUMB guidelines and recommendations for the clinical practice of contrast-enhanced ultrasound (CEUS) in non-hepatic applications: update 2017 (Short Version). Ultraschall Med. 2018; 39:154-180. 8. Machens A, Hauptmann S, Dralle H. Lymph node dissection in the lateral neck for completion in central node-positive papillary thyroid cancer. Surgery. 2009; 145:176-181. 42. Zhan J, Zhang LH, Yu Q, Li CL, Chen Y, Wang WP, Ding H. Prediction of cervical lymph node metastasis with contrast-enhanced ultrasound and association between presence of BRAF(V600E) and extrathyroidal extension in papillary thyroid carcinoma. Ther Adv Med Oncol. 2020; 12:1758835920942367. 31. Chen BD, Zhang Z, Wang KK, Shang MY, Zhao SS, Ding WB, Du R, Yu Z, Xu XM. A multivariable model of BRAFV600E and ultrasonographic features for predicting the risk of central lymph node metastasis in cN0 papillary thyroid microcarcinoma. Cancer Manag Res. 2019; 11:7211-7217. 1. Colonna M, Uhry Z, Guizard AV, Delafosse P, Schvartz C, Belot A, Grosclaude P; FRANCIM network. Recent trends in incidence, geographical distribution, and survival of papillary thyroid cancer in France. Cancer Epidemiol. 2015; 39:511-518. 50. Strouthos C, Lampaskis M, Sboros V, Mcneilly A, Averkiou M. Indicator dilution models for the quantification of microvascular blood flow with bolus administration of ultrasound contrast agents. IEEE Trans Ultrason Ferroelectr Freq Control. 2010; 57:1296-1310. 14. Jin WX, Ye DR, Sun YH, Zhou XF, Wang OC, Zhang XH, Cai YF. Prediction of central lymph node metastasis in papillary thyroid microcarcinoma according to clinicopathologic factors and thyroid nodule sonographic features: a case-control study. Cancer Manag Res. 2018; 10:3237-3243. 16. Chen J, Li XL, Zhang YF, Wang D, Wang Q, Zhao CK, Li MX, Wei Q, Ji G, Xu HX. Ultrasound validation of predictive model for central cervical lymph node metastasis in papillary thyroid cancer on BRAF. Future Oncol. 2020; 16:1607-1618. 30. Guo L, Ma YQ, Yao Y, Wu M, Deng ZH, Zhu FW, Luo YK, Tang J. Role of ultrasonographic features and quantified BRAFV600E mutation in lymph node metastasis in Chinese patients with papillary thyroid carcinoma. Sci Rep. 2019; 9:75. 49. Wei S, Fu N, Yao C, Liu P, Yang B. Two-and three-dimensional contrast-enhanced sonography for assessment of renal tumor vasculature: preliminary observations. J Ultrasound Med. 2013; 32:429-437. 20. Xu Y, Qi X, Zhao X, Ren W, Ding W. Clinical diagnostic value of contrast-enhanced ultrasound and TI-RADS classification for benign and malignant thyroid tumors: One comparative cohort study. Medicine (Baltimore). 2019; 98:e14051. 21. Deng J, Zhou P, Tian S, Zhang L, Li J, Qian Y. Comparison of diagnostic efficacy of contrast-enhanced ultrasound, acoustic radiation force impulse imaging, and their combined use in differentiating focal solid thyroid nodules. PLoS One. 2014; 9:e90674. 4. Sipos JA. Advances in ultrasound for the diagnosis and management of thyroid cancer. Thyroid. 2009; 19:1363-1372. 2. Al-Brahim N, Asa SL. Papillary thyroid carcinoma: An overview. Arch Pathol Lab Med. 2006; 130:1057-1062. 37. Wilsen CB, Patel MK, Douek ML, Masamed R, Dittmar KM, Lu DSK, Raman SS. Contrast-enhanced ultrasound for abdominal image-guided procedures. Abdom Radiol (NY). 2023; 48:1438-1453. 18. Chen M, Zhang K, Xu Y, Zhang S, Cao Y, Sun W. Shear wave elastography and contrast-enhanced ultrasonography in the diagnosis of thyroid malignant nodules. Mol Clin Oncol. 2016; 5:724-730. 38. Yu Y, Shi LL, Zhang HW, Wang Q. Performance of contrast-enhanced ultrasound for lymph node metastasis in papillary thyroid carcinoma: A meta-analysis. Endocr Connect. 2023; 12:e220341. 3. Pellegriti G, Frasca F, Regalbuto C, Squatrito S, Vigneri R. Worldwide increasing incidence of thyroid cancer: Update on epidemiology and risk factors. J Cancer Epidemiol. 2013; 2013:965212. 12. Zhao WJ, Luo H, Zhou YM, Dai WY, Zhu JQ. Evaluating the effectiveness of prophylactic central neck dissection with total thyroidectomy for cN0 papillary thyroid carcinoma: An updated meta-analysis. Eur J Surg Oncol. 2017; 43:1989-2000. 19. Trimboli P, Castellana M, Virili C, Havre RF, Bini F, Marinozzi F, D'Ambrosio F, Giorgino F, Giovanella L, Prosch H, Grani G, Radzina M, Cantisani V. Performance of contrast-enhanced ultrasound (CEUS) in assessing thyroid nodules: A systematic review and meta-analysis using histological standard of reference. Radiol Med. 2020; 125:406-415. 10. Liu C, Xiao C, Chen J, Li X, Feng Z, Gao Q, Liu Z. Risk factor analysis for predicting cervical lymph node metastasis in papillary thyroid carcinoma: a study of 966 patients. BMC Cancer. 2019; 19:622. 48. Tao L, Zhou W, Zhan W, Li W, Wang Y, Fan J. Preoperative prediction of cervical lymph node metastasis in papillary thyroid carcinoma via conventional and contrast-enhanced ultrasound. J Ultrasound Med. 2020; 39:2071-2080. 27. Huang C, Cong S, Liang T, Feng Z, Gan K, Zhou R, Guo Y, Luo S, Liang K, Wang Q. Development and validation of an ultrasound-based nomogram for preoperative prediction of cervical central lymph node metastasis in papillary thyroid carcinoma. Gland Surg. 2020; 9:956-967. 24. Liu W, Cheng R, Su Y, Diao C, Qian J, Zhang J, Ma Y, Fan Y. Risk factors of central lymph node metastasis of papillary thyroid carcinoma: A single-center retrospective analysis of 3273 cases. Medicine (Baltimore). 2017; 96:e8365. 34. Feng JW, Hong LZ, Wang F, Wu WX, Hu J, Liu SY, Jiang Y, Ye J. A nomogram based on clinical and ultrasound characteristics to predict central lymph node metastasis of papillary thyroid carcinoma. Front Endocrinol (Lausanne). 2021; 12:666315. 36. Ma J, Wang Y, Xi X, Tang J, Wang L, Wang L, Wang D, Liang X, Zhang B. Contrast-enhanced ultrasound combined targeted microbubbles for diagnosis of highly aggressive papillary thyroid carcinoma. Front Endocrinol (Lausanne). 2023; 14:1052862. 9. Haugen BR, Alexander EK, Bible KC, et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016; 26:1-133. 22. Liu Q, Cheng J, Li J, Gao X, Li H. The diagnostic accuracy of contrast-enhanced ultrasound for the differentiation of benign and malignant thyroid nodules: A PRISMA compliant meta-analysis. Medicine (Baltimore). 2018; 97:e13325. 28. Ji WL, Ya HL, Kai L, Bo H, Yue JZ, Hao TW, Tao Y. Clinicopathologic factors and preoperative ultrasonographic characteristics for predicting central lymph node metastasis in papillary thyroid microcarcinoma: A single center retrospective study. Braz J Otorhinolaryngol. 2022; 88:36-45. 40. Fang F, Gong Y, Liao L, Ye F, Zuo Z, Li X, Zhang Q, Tang K, Xu Y, Zhang R, Chen S, Niu C. Value of contrast-enhanced ultrasound for evaluation of cervical lymph node metastasis in papillary thyroid carcinoma. Front Endocrinol (Lausanne). 2022; 13:812475. 44. Perivoliotis K, Samara AA, Koutoukoglou P, Ntellas P, Dadouli K, Sotiriou S, Ioannou M, Tepetes K. Microvessel density in differentiated thyroid carcinoma: A systematic review and meta-analysis. World J Methodol. 2022; 12:448-458. 11. Viola D, Materazzi G, Valerio L, et al. Prophylactic central compartment lymph node dissection in papillary thyroid carcinoma: Clinical implications derived from the first prospective randomized controlled single institution study. J Clin Endocrinol Metab. 2015; 100:1316-1324. 46. Mori N, Mugikura S, Takahashi S, Ito K, Takasawa C, Li L, Miyashita M, Kasajima A, Mori Y, Ishida T, Kodama T, Takase K. Quantitative analysis of contrast-enhanced ultrasound imaging in invasive breast cancer: A novel technique to obtain histopathologic information of microvessel density. Ultrasound Med Biol. 2017; 43:607-614. 23. Ito Y, Fukushima M, Higashiyama T, Kihara M, Takamura Y, Kobayashi K, Miya A, Miyauchi A. Tumor size is the strongest predictor of microscopic lymph node metastasis and lymph node recurrence of N0 papillary thyroid carcinoma. Endocr J. 2013; 60:113-117. 26. Yao X, Meng Y, Guo R, Lu G, Jin L, Wang Y, Yang D. Value of ultrasound combined with immunohistochemistry evaluation of central lymph node metastasis for the prognosis of papillary thyroid carcinoma. Cance 44 45 46 47 48 49 50 51 10 11 12 13 14 15 16 17 18 19 1 2 3 4 5 6 7 8 9 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 |
References_xml | – reference: 46. Mori N, Mugikura S, Takahashi S, Ito K, Takasawa C, Li L, Miyashita M, Kasajima A, Mori Y, Ishida T, Kodama T, Takase K. Quantitative analysis of contrast-enhanced ultrasound imaging in invasive breast cancer: A novel technique to obtain histopathologic information of microvessel density. Ultrasound Med Biol. 2017; 43:607-614. – reference: 21. Deng J, Zhou P, Tian S, Zhang L, Li J, Qian Y. Comparison of diagnostic efficacy of contrast-enhanced ultrasound, acoustic radiation force impulse imaging, and their combined use in differentiating focal solid thyroid nodules. PLoS One. 2014; 9:e90674. – reference: 3. Pellegriti G, Frasca F, Regalbuto C, Squatrito S, Vigneri R. Worldwide increasing incidence of thyroid cancer: Update on epidemiology and risk factors. J Cancer Epidemiol. 2013; 2013:965212. – reference: 22. Liu Q, Cheng J, Li J, Gao X, Li H. The diagnostic accuracy of contrast-enhanced ultrasound for the differentiation of benign and malignant thyroid nodules: A PRISMA compliant meta-analysis. Medicine (Baltimore). 2018; 97:e13325. – reference: 35. Sidhu P, Cantisani V, Dietrich C, et al. The EFSUMB guidelines and recommendations for the clinical practice of contrast-enhanced ultrasound (CEUS) in non-hepatic applications: update 2017 (Short Version). Ultraschall Med. 2018; 39:154-180. – reference: 47. Liu Y, Zhou H, Yang P, Zhou Y, Wu J, Chen C, Ye M, Luo J. Contrast-enhanced ultrasonography features of papillary thyroid carcinoma for predicting cervical lymph node metastasis. Exp Ther Med. 2017; 14:4321-4327. – reference: 43. Liu Z, Li C. Correlation of lymph node metastasis with contrast-enhanced ultrasound features, microvessel density and microvessel area in patients with papillary thyroid carcinoma. Clin Hemorheol Microcirc. 2022; 82:361-370. – reference: 31. Chen BD, Zhang Z, Wang KK, Shang MY, Zhao SS, Ding WB, Du R, Yu Z, Xu XM. A multivariable model of BRAFV600E and ultrasonographic features for predicting the risk of central lymph node metastasis in cN0 papillary thyroid microcarcinoma. Cancer Manag Res. 2019; 11:7211-7217. – reference: 32. Xu JM, Xu HX, Li XL, Bo XW, Xu XH, Zhang YF, Guo LH, Liu LN, Qu S. A risk model for predicting central lymph node metastasis of papillary thyroid microcarcinoma including conventional ultrasound and acoustic radiation force impulse elastography. Medicine (Baltimore). 2016; 95:e2558. – reference: 20. Xu Y, Qi X, Zhao X, Ren W, Ding W. Clinical diagnostic value of contrast-enhanced ultrasound and TI-RADS classification for benign and malignant thyroid tumors: One comparative cohort study. Medicine (Baltimore). 2019; 98:e14051. – reference: 15. Li J, Liu J, Qian L. Suspicious ultrasound characteristics correlate with multiple factors that predict central lymph node metastasis of papillary thyroid carcinoma: Significant role of HBME-1. Eur J Radiol. 2020; 123:108801. – reference: 29. Luo X, Wang J, Xu M, Zou X, Lin Q, Zheng W, Guo Z, Li A, Han F. Risk model and risk stratification to preoperatively predict central lymph node metastasis in papillary thyroid carcinoma. Gland Surg. 2020; 9:300-310. – reference: 24. Liu W, Cheng R, Su Y, Diao C, Qian J, Zhang J, Ma Y, Fan Y. Risk factors of central lymph node metastasis of papillary thyroid carcinoma: A single-center retrospective analysis of 3273 cases. Medicine (Baltimore). 2017; 96:e8365. – reference: 9. Haugen BR, Alexander EK, Bible KC, et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016; 26:1-133. – reference: 17. Kouvaraki MA, Shapiro SE, Fornage BD, Edeiken-Monro BS, Sherman SI, Vassilopoulou-Sellin R, Lee JE, Evans DB. Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer. Surgery. 2003; 134:946-954. – reference: 48. Tao L, Zhou W, Zhan W, Li W, Wang Y, Fan J. Preoperative prediction of cervical lymph node metastasis in papillary thyroid carcinoma via conventional and contrast-enhanced ultrasound. J Ultrasound Med. 2020; 39:2071-2080. – reference: 4. Sipos JA. Advances in ultrasound for the diagnosis and management of thyroid cancer. Thyroid. 2009; 19:1363-1372. – reference: 33. Das DK, Sheikh ZA, George SS, Al-Baquer T, Francis IM. Papillary thyroid carcinoma: Evidence for intracytoplasmic formation of precursor substance for calcification and its release from well-preserved neoplastic cells. Diagn Cytopathol. 2008; 36:809-812. – reference: 14. Jin WX, Ye DR, Sun YH, Zhou XF, Wang OC, Zhang XH, Cai YF. Prediction of central lymph node metastasis in papillary thyroid microcarcinoma according to clinicopathologic factors and thyroid nodule sonographic features: a case-control study. Cancer Manag Res. 2018; 10:3237-3243. – reference: 2. Al-Brahim N, Asa SL. Papillary thyroid carcinoma: An overview. Arch Pathol Lab Med. 2006; 130:1057-1062. – reference: 49. Wei S, Fu N, Yao C, Liu P, Yang B. Two-and three-dimensional contrast-enhanced sonography for assessment of renal tumor vasculature: preliminary observations. J Ultrasound Med. 2013; 32:429-437. – reference: 27. Huang C, Cong S, Liang T, Feng Z, Gan K, Zhou R, Guo Y, Luo S, Liang K, Wang Q. Development and validation of an ultrasound-based nomogram for preoperative prediction of cervical central lymph node metastasis in papillary thyroid carcinoma. Gland Surg. 2020; 9:956-967. – reference: 7. Zhang L, Yang J, Sun Q, Liu Y, Liang F, Liu Z, Chen G, Chen S, Shang Z, Li Y, Li X. Risk factors for lymph node metastasis in papillary thyroid microcarcinoma: older patients with fewer lymph node metastases. Eur J Surg Oncol. 2016; 42:1478-1482. – reference: 16. Chen J, Li XL, Zhang YF, Wang D, Wang Q, Zhao CK, Li MX, Wei Q, Ji G, Xu HX. Ultrasound validation of predictive model for central cervical lymph node metastasis in papillary thyroid cancer on BRAF. Future Oncol. 2020; 16:1607-1618. – reference: 41. Zhan J, Diao X, Chen Y, Wang W, Ding H. Predicting cervical lymph node metastasis in patients with papillary thyroid cancer (PTC) - Why contrast-enhanced ultrasound (CEUS) was performed before thyroidectomy. Clin Hemorheol Microcirc. 2019; 72:61-73. – reference: 26. Yao X, Meng Y, Guo R, Lu G, Jin L, Wang Y, Yang D. Value of ultrasound combined with immunohistochemistry evaluation of central lymph node metastasis for the prognosis of papillary thyroid carcinoma. Cancer Manag Res. 2020; 12:8787-8799. – reference: 5. Baek SK, Jung KY, Kang SM, Kwon SY, Woo JS, Cho SH, Chung EJ. Clinical risk factors associated with cervical lymph node recurrence in papillary thyroid carcinoma. Thyroid. 2010; 20:147-152. – reference: 6. Xu S, Yao J, Zhou W, Chen L, Zhan W. Clinical characteristics and ultrasonographic features for predicting central lymph node metastasis in clinically node‐negative papillary thyroid carcinoma without capsule invasion. Head Neck. 2019; 41:3984-3991. – reference: 18. Chen M, Zhang K, Xu Y, Zhang S, Cao Y, Sun W. Shear wave elastography and contrast-enhanced ultrasonography in the diagnosis of thyroid malignant nodules. Mol Clin Oncol. 2016; 5:724-730. – reference: 25. Perrier ND, Brierley JD, Tuttle RM. Differentiated and anaplastic thyroid carcinoma: Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin. 2018; 68:55-63. – reference: 36. Ma J, Wang Y, Xi X, Tang J, Wang L, Wang L, Wang D, Liang X, Zhang B. Contrast-enhanced ultrasound combined targeted microbubbles for diagnosis of highly aggressive papillary thyroid carcinoma. Front Endocrinol (Lausanne). 2023; 14:1052862. – reference: 45. Zhan W, Zhou P, Zhou J, Xu S, Chen K. Differences in sonographic features of papillary thyroid carcinoma between neck lymph node metastatic and nonmetastatic groups. J Ultrasound Med. 2012; 31:915-920. – reference: 13. Zhao C, Jiang W, Gao Y, Niu W, Zhang X, Xin L. Risk factors for lymph node metastasis (LNM) in patients with papillary thyroid microcarcinoma (PTMC): role of preoperative ultrasound. J Int Med Res. 2017; 45:1221-1230. – reference: 38. Yu Y, Shi LL, Zhang HW, Wang Q. Performance of contrast-enhanced ultrasound for lymph node metastasis in papillary thyroid carcinoma: A meta-analysis. Endocr Connect. 2023; 12:e220341. – reference: 34. Feng JW, Hong LZ, Wang F, Wu WX, Hu J, Liu SY, Jiang Y, Ye J. A nomogram based on clinical and ultrasound characteristics to predict central lymph node metastasis of papillary thyroid carcinoma. Front Endocrinol (Lausanne). 2021; 12:666315. – reference: 39. Li QL, Ma T, Wang ZJ, Huang L, Liu W, Chen M, Sang T, Ren XG, Tong J, Cao CL, Dong J, Li J. The value of contrast-enhanced ultrasound for the diagnosis of metastatic cervical lymph nodes of papillary thyroid carcinoma: A systematic review and meta-analysis. J Clin Ultrasound. 2022; 50:60-69. – reference: 11. Viola D, Materazzi G, Valerio L, et al. Prophylactic central compartment lymph node dissection in papillary thyroid carcinoma: Clinical implications derived from the first prospective randomized controlled single institution study. J Clin Endocrinol Metab. 2015; 100:1316-1324. – reference: 30. Guo L, Ma YQ, Yao Y, Wu M, Deng ZH, Zhu FW, Luo YK, Tang J. Role of ultrasonographic features and quantified BRAFV600E mutation in lymph node metastasis in Chinese patients with papillary thyroid carcinoma. Sci Rep. 2019; 9:75. – reference: 19. Trimboli P, Castellana M, Virili C, Havre RF, Bini F, Marinozzi F, D'Ambrosio F, Giorgino F, Giovanella L, Prosch H, Grani G, Radzina M, Cantisani V. Performance of contrast-enhanced ultrasound (CEUS) in assessing thyroid nodules: A systematic review and meta-analysis using histological standard of reference. Radiol Med. 2020; 125:406-415. – reference: 1. Colonna M, Uhry Z, Guizard AV, Delafosse P, Schvartz C, Belot A, Grosclaude P; FRANCIM network. Recent trends in incidence, geographical distribution, and survival of papillary thyroid cancer in France. Cancer Epidemiol. 2015; 39:511-518. – reference: 23. Ito Y, Fukushima M, Higashiyama T, Kihara M, Takamura Y, Kobayashi K, Miya A, Miyauchi A. Tumor size is the strongest predictor of microscopic lymph node metastasis and lymph node recurrence of N0 papillary thyroid carcinoma. Endocr J. 2013; 60:113-117. – reference: 12. Zhao WJ, Luo H, Zhou YM, Dai WY, Zhu JQ. Evaluating the effectiveness of prophylactic central neck dissection with total thyroidectomy for cN0 papillary thyroid carcinoma: An updated meta-analysis. Eur J Surg Oncol. 2017; 43:1989-2000. – reference: 8. Machens A, Hauptmann S, Dralle H. Lymph node dissection in the lateral neck for completion in central node-positive papillary thyroid cancer. Surgery. 2009; 145:176-181. – reference: 42. Zhan J, Zhang LH, Yu Q, Li CL, Chen Y, Wang WP, Ding H. Prediction of cervical lymph node metastasis with contrast-enhanced ultrasound and association between presence of BRAF(V600E) and extrathyroidal extension in papillary thyroid carcinoma. Ther Adv Med Oncol. 2020; 12:1758835920942367. – reference: 37. Wilsen CB, Patel MK, Douek ML, Masamed R, Dittmar KM, Lu DSK, Raman SS. Contrast-enhanced ultrasound for abdominal image-guided procedures. Abdom Radiol (NY). 2023; 48:1438-1453. – reference: 28. Ji WL, Ya HL, Kai L, Bo H, Yue JZ, Hao TW, Tao Y. Clinicopathologic factors and preoperative ultrasonographic characteristics for predicting central lymph node metastasis in papillary thyroid microcarcinoma: A single center retrospective study. Braz J Otorhinolaryngol. 2022; 88:36-45. – reference: 51. Luo Y, Zhao Y, Chen K, Shen J, Shi J, Lu S, Lei J, Li Z, Luo D. Clinical analysis of cervical lymph node metastasis risk factors in patients with papillary thyroid microcarcinoma. J Endocrinol Invest. 2019; 42:227-236. – reference: 10. Liu C, Xiao C, Chen J, Li X, Feng Z, Gao Q, Liu Z. Risk factor analysis for predicting cervical lymph node metastasis in papillary thyroid carcinoma: a study of 966 patients. BMC Cancer. 2019; 19:622. – reference: 44. Perivoliotis K, Samara AA, Koutoukoglou P, Ntellas P, Dadouli K, Sotiriou S, Ioannou M, Tepetes K. Microvessel density in differentiated thyroid carcinoma: A systematic review and meta-analysis. World J Methodol. 2022; 12:448-458. – reference: 40. Fang F, Gong Y, Liao L, Ye F, Zuo Z, Li X, Zhang Q, Tang K, Xu Y, Zhang R, Chen S, Niu C. Value of contrast-enhanced ultrasound for evaluation of cervical lymph node metastasis in papillary thyroid carcinoma. Front Endocrinol (Lausanne). 2022; 13:812475. – reference: 50. Strouthos C, Lampaskis M, Sboros V, Mcneilly A, Averkiou M. Indicator dilution models for the quantification of microvascular blood flow with bolus administration of ultrasound contrast agents. IEEE Trans Ultrason Ferroelectr Freq Control. 2010; 57:1296-1310. – ident: 5 doi: 10.1089/thy.2008.0243 – ident: 2 doi: 10.5858/2006-130-1057-PTCAO – ident: 33 doi: 10.1002/dc.20898 – ident: 35 doi: 10.1055/s-0044-101254 – ident: 47 doi: 10.3892/etm.2017.5087 – ident: 20 doi: 10.1097/MD.0000000000014051 – ident: 22 doi: 10.1097/MD.0000000000013325 – ident: 15 doi: 10.1016/j.ejrad.2019.108801 – ident: 42 doi: 10.1177/1758835920942367 – ident: 3 doi: 10.1155/2013/965212 – ident: 44 doi: 10.5662/wjm.v12.i5.448 – ident: 14 doi: 10.2147/CMAR.S169741 – ident: 37 doi: 10.1007/s00261-023-03804-5 – ident: 26 doi: 10.2147/CMAR.S265756 – ident: 36 doi: 10.3389/fendo.2023.1052862 – ident: 18 doi: 10.3892/mco.2016.1053 – ident: 21 doi: 10.1371/journal.pone.0090674 – ident: 9 doi: 10.1089/thy.2015.0020 – ident: 25 doi: 10.3322/caac.21439 – ident: 46 doi: 10.1016/j.ultrasmedbio.2016.11.009 – ident: 12 doi: 10.1016/j.ejso.2017.07.008 – ident: 31 doi: 10.2147/CMAR.S199921 – ident: 34 doi: 10.3389/fendo.2021.666315 – ident: 10 doi: 10.1186/s12885-019-5835-6 – ident: 32 doi: 10.1097/MD.0000000000002558 – ident: 24 doi: 10.1097/MD.0000000000008365 – ident: 30 doi: 10.1038/s41598-018-36171-z – ident: 50 doi: 10.1109/TUFFC.2010.1550 – ident: 6 doi: 10.1002/hed.25941 – ident: 17 doi: 10.1016/S0039-6060(03)00424-0 – ident: 28 doi: 10.1016/j.bjorl.2020.05.004 – ident: 48 doi: 10.1002/jum.15315 – ident: 8 doi: 10.1016/j.surg.2008.09.003 – ident: 40 doi: 10.3389/fendo.2022.812475 – ident: 19 doi: 10.1007/s11547-019-01129-2 – ident: 39 doi: 10.1002/jcu.23073 – ident: 27 doi: 10.21037/gs-20-75 – ident: 7 doi: 10.1016/j.ejso.2016.07.002 – ident: 4 doi: 10.1089/thy.2009.1608 – ident: 1 doi: 10.1016/j.canep.2015.04.015 – ident: 49 doi: 10.7863/jum.2013.32.3.429 – ident: 43 doi: 10.3233/CH-221545 – ident: 16 doi: 10.2217/fon-2020-0069 – ident: 11 doi: 10.1210/jc.2014-3825 – ident: 29 doi: 10.21037/gs.2020.03.02 – ident: 38 doi: 10.1530/EC-22-0341 – ident: 51 doi: 10.1007/s40618-018-0908-y – ident: 41 doi: 10.3233/CH-180454 – ident: 23 doi: 10.1507/endocrj.EJ12-0311 – ident: 45 doi: 10.7863/jum.2012.31.6.915 – ident: 13 doi: 10.1177/0300060517708943 |
SSID | ssj0000548185 |
Score | 2.286321 |
Snippet | Papillary thyroid carcinoma (PTC), the most common endocrine tumor, often spreads to cervical lymph nodes metastasis (CLNM). Preoperative diagnosis of CLNM is... |
SourceID | pubmed crossref jstage |
SourceType | Index Database Publisher |
StartPage | 44 |
SubjectTerms | cervical lymph node metastasis contrast-enhanced ultrasound papillary thyroid carcinoma quantitative parameter |
Title | Quantitative parameters of contrast-enhanced ultrasound effectively promote the prediction of cervical lymph node metastasis in papillary thyroid carcinoma |
URI | https://www.jstage.jst.go.jp/article/ddt/18/1/18_2023.01095/_article/-char/en https://www.ncbi.nlm.nih.gov/pubmed/38355122 |
Volume | 18 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Drug Discoveries & Therapeutics, 2024/02/29, Vol.18(1), pp.44-53 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9MwGLa6jQMXxDfdYPIBjcOWESdpPg4cNsZUIW0qokjjFMWJvQaNZOqSQ_kr_Bb-G-9ru07a7TC4RJVrW6mep--H3w8T8nbEpccjr3A4eD9OkOeekxVh4ESguhJXuolMsN757Dwcfws-X4wuBoM_vayltuGH-a8760r-B1UYA1yxSvYfkLWbwgB8BnzhCQjD814Yf2mzShWJYfoPNvH-icktNzpVHE9tbxpHVDMd5G-vcABvUTJJHLAIjzZUPp4wJVMYtlnakLkSIwDh1QIg369qTHYVDWyaYRcT1ZT1Gi8tmoMFO1vM67LARtd5WdVG2Buj92TeXmIkKMd00VKd84b7vcIva9Z_bRXdyqy2eUK6eBuviO6G1KzvoHPzWVutDY_bsn-Q4QWqMDzpyd44Zk4UG6Ug-mM6ifO2wLbE1NJXd5I0elz3IF7XEKNRjB1niwLzaD3_ECODo04XLuP_ayrSJi6Cy4Q7pLA-xfWpWr9BtjzwUkDMbh0dnxyf2kM-sIfRIEKnf_njdONQ3OT96kusGEYPfgCW2PRhxddRNs_0MXlknBV6pJn3hAxE9ZTsTXS388UBnfYwPKB7dNL1QV88I7_79KQdPWkt6S160o6etEdPauhJgS60o6fawtCTKnpSpCft6EnLilp6UkNPaun5nExPP00_jh1zF4iTg4PcODJjmZBFwZOIMQwuh4HLeOSyIgGDOud4gRIDKSNdNy-yJMgkkyFjifBDnifcf0E2q7oSrwiNCz8SkceFG_NAhjwOfVcKj8dBxpNMiCF5t8QhvdYdX9K7YR-SDxomO89IAjWPxSnDRzfffo0FlSC_huSlRteu98EfAgvc2773O-yQh91_6TXZbOateANmcsN3DRl3ycb55OwvkaHJvQ |
linkProvider | EBSCOhost |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Quantitative+parameters+of+contrast-enhanced+ultrasound+effectively+promote+the+prediction+of+cervical+lymph+node+metastasis+in+papillary+thyroid+carcinoma&rft.jtitle=Drug+discoveries+%26+therapeutics&rft.au=Su%2C+Biao&rft.au=Li%2C+Lisha&rft.au=Liu%2C+Yingchun&rft.au=Liu%2C+Hui&rft.date=2024-02-29&rft.issn=1881-7831&rft.eissn=1881-784X&rft.volume=18&rft.issue=1&rft.spage=44&rft.epage=53&rft_id=info:doi/10.5582%2Fddt.2023.01095&rft.externalDBID=n%2Fa&rft.externalDocID=10_5582_ddt_2023_01095 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1881-7831&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1881-7831&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1881-7831&client=summon |